The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study

Jerzy Wydmański; Rafal Suwinski; Stanislaw Poltorak; Bogusław Maka; Leszek Miszczyk; Edyta Wolny; Grzegorz Bielaczyc; Aleksander Zajusz

doi:10.1016/j.radonc.2007.01.009

The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study

Radiother Oncol. 2007 Feb;82(2):132-6. doi: 10.1016/j.radonc.2007.01.009. Epub 2007 Feb 6.

Authors

Jerzy Wydmański¹, Rafal Suwinski, Stanislaw Poltorak, Bogusław Maka, Leszek Miszczyk, Edyta Wolny, Grzegorz Bielaczyc, Aleksander Zajusz

Affiliation

¹ Department of Conventional and Intraoperative Radiotherapy, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland. [email protected]

PMID: 17287038
DOI: 10.1016/j.radonc.2007.01.009

Abstract

The aim of study was to assess the tolerance and effectiveness of preoperative chemoradiotherapy in the group of 40 patients with operable gastric cancer. The therapy was well tolerated. We observed the high rate of pathological response and R0 resections, low rate of local recurrence and high percent of 2-year survival.

Publication types

Clinical Trial, Phase II

MeSH terms

Adenocarcinoma / therapy*
Adult
Aged
Antimetabolites, Antineoplastic / therapeutic use
Female
Fluorouracil / therapeutic use
Gastrectomy
Humans
Male
Middle Aged
Neoadjuvant Therapy
Radiotherapy Dosage
Stomach Neoplasms / therapy*
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Fluorouracil